Skip to contentClarengateINTELLIGENCE
Companies/08335008

Isomerase Therapeutics Limited

Private Limited Company · Cambridge

ActiveUnited KingdomIncorporated 2012Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · company scope

Net assets
£2,716,490
Cash
£1,832,796
Turnover
—
Profit / loss
—
Current assets
£2,597,139
Creditors < 1 year
£222,200
Equity
£2,716,490
Average employees
38

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

3 periods
Reported figures2025-12-31GBP · company2024-12-31GBP · company2023-12-31GBP · company
Balance sheet
Net assets£2,716,490£2,914,886£2,828,267
Equity£2,716,490£2,914,886£2,828,267
Assets
Fixed assets£341,551£506,836—
Intangible assets£3,578£5,125£6,672
Property, plant & equipment£337,973£501,711£586,442
Current assets£2,597,139£2,892,633£2,722,054
Cash at bank£1,832,796£1,393,735£1,743,328
Debtors£746,884£1,485,063£978,726
Stock£17,459£13,835—
Liabilities
Creditors within one year£222,200£484,583£486,901
Net current assets£2,374,939£2,408,050£2,235,153
Assets less current liabilities£2,716,490£2,914,886£2,828,267
People
Average employees383737
Source evidenceView filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.